Skip to main content
. 2024 Mar 14;70:102479. doi: 10.1016/j.eclinm.2024.102479

Table 1.

Patient characteristics in the curated evaluation dataset.

Characteristics Num. Cases (%)
No. of cases 5420
No. of images included in study 14,303
No. of patients included in study 4180
Female (%) 2980 (55.0%)
Age, median (25th, 75th percentiles) 55 (39, 67)
Race and ethnicitya
 White, non-Hispanic (%) 698 (32.2%)
 Asian and Pacific Islander, non-Hispanic (%) 261 (12.0%)
 Hispanic (%) 867 (40.0%)
 Black, non-Hispanic (%) 291 (13.4%)
 Other/Not specified (%) 51 (2.4%)
Estimated Fitzpatrick skin types
 I or II (%) 2621 (48.4%)
 III or IV (%) 2026 (37.4%)
 V or VI (%) 262 (4.8%)
 N/A (%) 511 (9.4%)
Skin conditions based on reference diagnosis Num. Cases (%) Skin conditions based on reference diagnosis Num. Cases (%)
Acne 135 (2.5%) Psoriasis 93 (1.7%)
Actinic keratosis 357 (6.6%) SCC/SCCISb 493 (9.1%)
Allergic contact dermatitis 57 (1.1%) SK/ISK 377 (7.0%)
Alopecia areata 46 (0.8%) Scar condition 61 (1.1%)
Androgenetic alopecia 45 (0.8%) Seborrheic dermatitis 46 (0.8%)
Basal cell carcinomab 518 (9.6%) Skin tag 37 (0.7%)
Cyst 111 (2.0%) Stasis dermatitis 36 (0.7%)
Eczema 159 (2.9%) Tinea 35 (0.6%)
Folliculitis 53 (1.0%) Tinea versicolor 31 (0.6%)
Hidradenitis 44 (0.8%) Urticaria 17 (0.3%)
Lentigo 152 (2.8%) Verruca vulgaris 44 (0.8%)
Melanocytic nevus 563 (10.4%) Vitiligo 41 (0.8%)
Melanomab 195 (3.6%) Other condition 1636 (30.2%)
Post-inflammatory hyperpigmentation 38 (0.7%)

Enrichment was performed to mitigate skew towards common demographics and dermatologic conditions, and additionally to include all available cases with race/ethnicity information. The table includes 26 common skin conditions, representing 80% of cases seen in primary care,20 and an additional category grouping other conditions.

a

Race/ethnicity information was unavailable for the skin cancer dataset. Case counts and percentages for race/ethnicity therefore reflect only cases from the tele-dermatology dataset where race/ethnicity was generally available.

b

Skin cancers.